EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Interpretable Four-Gene Cell-Cycle Signature Links Malignant Progression to Adverse Survival in Adult Primary Diffuse Glioma: A CGGA Transcriptome Study

Hongkai Jia, Nan Pu, Chunyan Tian

Genes · 21.07.2026 · 17 (7) · 833

DOI: 10.3390/genes17070833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 21.07.2026. Verfasst von Hongkai Jia und 2 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Peking University Institute of Nephrology, Peking University First Hospital & Key Laboratory of Renal Disease, Ministry of Health of …. Hauptthemen laut MEDLINE: Glioma, Transcriptome, Brain Neoplasms, Cell Cycle Proteins. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adult diffuse gliomas are biologically heterogeneous and clinically lethal. We evaluated whether a compact transcriptomic program could summarize malignant progression and adverse survival.

Methods

We analyzed adult primary WHO grades II–IV gliomas from the CGGA mRNAseq_693 cohort and used CGGA mRNAseq_325 as an independent validation cohort. CDK1, CCNB2, CDCA3, and PTTG1 were prioritized through a transparent, literature-informed mitotic-gene framework. Four classifiers were evaluated by five-fold cross-validation repeated 20 times, with all preprocessing restricted to each training fold. A training-defined four-gene score was assessed by Kaplan–Meier and Cox models.

Results

The primary cohort contained 415 tumors, including 396 with evaluable survival. We identified 773 differentially expressed genes between WHO grade IV and WHO grades II/III tumors, and all four candidate genes increased monotonically with grade. In repeated cross-validation, the SVM achieved the highest mean AUROC of 0.793 ± 0.048 (95% CI 0.784–0.802), with average precision of 0.701 ± 0.063. In the independent CGGA mRNAseq_325 cohort (n = 226), logistic regression achieved an AUROC of 0.792. The four-gene score and a broader four-marker proliferation index showed similar discrimination, supporting the interpretation of the signature as a compact proliferation-axis proxy. The training-set median cut-off was −0.153. The score remained associated with shorter survival after adjustment for age, grade, and IDH status in the primary cohort (n = 359; HR = 1.28, 95% CI 1.10–1.49; p = 0.002) and in the independent cohort (n = 217; HR = 1.58, 95% CI 1.25–2.00; p < 0.001).

Conclusions

The four-gene score captures grade-associated proliferative biology and reproducible survival risk across two CGGA cohorts. It is a research biomarker rather than a standalone diagnostic or clinical decision tool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaTranscriptomeBrain NeoplasmsCell Cycle ProteinsHumansCDC2 Protein KinaseGene Expression Regulation, NeoplasticFemaleCyclin B2MaleBiomarkers, TumorSecurinAdultGene Expression ProfilingDisease ProgressionMiddle AgedCell CyclePrognosis

Stichwörter der Autor:innen

CCNB2CDCA3CDK1Chinese Glioma Genome AtlasPTTG1adult diffuse gliomamachine learningsurvival signaturetranscriptomics

Substanzen

CDC2 Protein KinaseCyclin B2Biomarkers, TumorCell Cycle ProteinsCCNB2 protein, humanSecurinCDK1 protein, humanpituitary tumor-transforming protein 1, human

Autor:innen und Institutionen

  • Renal Division, Peking University Institute of Nephrology, Peking University First Hospital & Key Laboratory of Renal Disease, Ministry of Health of China & Key Laboratory of Chronic Kidney Disease Prevention and Treatm…
  • College of Bioengineering, Beijing Polytechnic University, Beijing 100176, China.
  • Department of Ultrasound Medicine, People's Hospital of Yubei District, Chongqing 401120, China.

Zitieren

APA

Jia, H., Pu, N., & Tian, C. (2026). An Interpretable Four-Gene Cell-Cycle Signature Links Malignant Progression to Adverse Survival in Adult Primary Diffuse Glioma: A CGGA Transcriptome Study. Genes, 17(7), 833. https://doi.org/10.3390/genes17070833

Vancouver

Jia H, Pu N, Tian C. An Interpretable Four-Gene Cell-Cycle Signature Links Malignant Progression to Adverse Survival in Adult Primary Diffuse Glioma: A CGGA Transcriptome Study. Genes. 2026;17(7):833. doi:10.3390/genes17070833

BibTeX
@article{Jia2026,
  author = {Jia, Hongkai and Pu, Nan and Tian, Chunyan},
  title = {An Interpretable Four-Gene Cell-Cycle Signature Links Malignant Progression to Adverse Survival in Adult Primary Diffuse Glioma: A CGGA Transcriptome Study},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {7},
  pages = {833},
  doi = {10.3390/genes17070833}
}
Kostenlos starten →